Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

• Main Authors: Marco Carli (Author), Shivakumar Kolachalam (Author), Biancamaria Longoni (Author), Anna Pintaudi (Author), Marco Baldini (Author), Stefano Aringhieri (Author), Irene Fasciani (Author), Paolo Annibale (Author), Roberto Maggio (Author), Marco Scarselli (Author)
• Format: Book
• Published: MDPI AG, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia, bipolar disorders and other psychotic disorders. However, they might cause metabolic syndrome (MetS) in terms of weight gain, dyslipidemia, type 2 diabetes (T2D), and high blood pressure, which are responsible...